{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4628",
      "entity_text" : "OA",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P0CW71",
      "entity_text" : "MCP-1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, in the MRL-lpr mouse model of arthritis, treatment with an MCP-1 antagonist, MCP-1 (9-76), prior to disease onset greatly reduced OA progression whereas native MCP-1 enhanced the onset and aggravated joint inflammation [XREF_BIBR].",
  "reading_complete" : "2020-07-28T18:36:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T18:29:16Z",
  "trigger" : "reduced",
  "evidence" : [ "MCP-1 antagonist, MCP-1 (9-76), prior to disease onset greatly reduced OA" ],
  "pmc_id" : "7307639",
  "score" : 0
}